CTOs on the Move

Fortus Healthcare Resources

www.fortusgroup.com

 
For more than 20 years, Fortus Healthcare Resources has embraced a personalized approach to recruiting. With a candidate database unmatched in the industry, we value our relationship with clients and candidates. The Fortus Group is the pioneer of dialysis recruitment. Since 1993, we have been committed to providing recruitment solutions for the dialysis industry with much success and growth. Our organization has expanded from a one-desk specialty recruiter to a state-of-the-art facility. With a staff of over 30, we continue to maintain the largest recruiting staff industrywide. Our company`s 100+ years combined dialysis recruiting experience enables us to provide the ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Parkcliffe

Parkcliffe is a Toledo, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Addiction Recovery Care

Addiction Recovery Care provides residential and outpatient drug and alcohol addiction treatment.

SPEAR Physical Therapy

The American Physical Therapy Associations top-ranked private physical therapy practice, and the top-rated physical therapists in New York City.

Adheris

Adheris is a Burlington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.